Book contents
- Seminars in Clinical Psychopharmacology
- College Seminars Series
- Seminars in Clinical Psychopharmacology
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Editor’s Note on Nomenclature
- Neuroscience-Based Nomenclature Glossary
- Abbreviations
- Part 1 Basic Science and General Principles
- Part 2 Psychopharmacology of the Main Psychotropic Drug Groups
- Chapter 7 Drugs to Treat Depression
- Chapter 8 Drugs to Treat Anxiety and Insomnia
- Chapter 9 Drugs to Treat Schizophrenia and Psychosis (Dopamine Antagonists and Partial Agonists Other Than Clozapine)
- Chapter 10 Clozapine
- 10.1 Introduction and Brief History
- 10.2 Efficacy in Schizophrenia
- 10.3 At What Stage Should Clozapine Be Used in Schizophrenia?
- 10.4 Effectiveness in Treatment-Resistant Schizophrenia
- 10.5 Clozapine Augmentation in Schizophrenia
- 10.6 Clozapine in Other Psychiatric Disorders
- 10.7 Adverse Effects
- 10.8 Pharmacokinetics
- 10.9 Rechallenge and Continuation
- 10.10 Summary
- Contents
- Chapter 11 Lithium
- Chapter 12 Anticonvulsants for Mental Disorders: Valproate, Lamotrigine, Carbamazepine and Oxcarbazepine
- Chapter 13 Drugs to Treat Attention Deficit Hyperactivity Disorder (ADHD)
- Chapter 14 Drugs to Treat Dementia
- Chapter 15 Drugs to Treat Substance Use Disorders
- Chapter 16 Electroconvulsive Therapy and Neuromodulation Therapies
- Part 3 Specific Therapeutic Areas
- Index
Contents
from Chapter 10 - Clozapine
Published online by Cambridge University Press: 29 May 2020
- Seminars in Clinical Psychopharmacology
- College Seminars Series
- Seminars in Clinical Psychopharmacology
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Editor’s Note on Nomenclature
- Neuroscience-Based Nomenclature Glossary
- Abbreviations
- Part 1 Basic Science and General Principles
- Part 2 Psychopharmacology of the Main Psychotropic Drug Groups
- Chapter 7 Drugs to Treat Depression
- Chapter 8 Drugs to Treat Anxiety and Insomnia
- Chapter 9 Drugs to Treat Schizophrenia and Psychosis (Dopamine Antagonists and Partial Agonists Other Than Clozapine)
- Chapter 10 Clozapine
- 10.1 Introduction and Brief History
- 10.2 Efficacy in Schizophrenia
- 10.3 At What Stage Should Clozapine Be Used in Schizophrenia?
- 10.4 Effectiveness in Treatment-Resistant Schizophrenia
- 10.5 Clozapine Augmentation in Schizophrenia
- 10.6 Clozapine in Other Psychiatric Disorders
- 10.7 Adverse Effects
- 10.8 Pharmacokinetics
- 10.9 Rechallenge and Continuation
- 10.10 Summary
- Contents
- Chapter 11 Lithium
- Chapter 12 Anticonvulsants for Mental Disorders: Valproate, Lamotrigine, Carbamazepine and Oxcarbazepine
- Chapter 13 Drugs to Treat Attention Deficit Hyperactivity Disorder (ADHD)
- Chapter 14 Drugs to Treat Dementia
- Chapter 15 Drugs to Treat Substance Use Disorders
- Chapter 16 Electroconvulsive Therapy and Neuromodulation Therapies
- Part 3 Specific Therapeutic Areas
- Index
- Type
- Chapter
- Information
- Seminars in Clinical Psychopharmacology , pp. 326Publisher: Cambridge University PressPrint publication year: 2020